CVE-2017-12720
An Improper Access Control issue was discovered in Smiths Medical Medfusion 4000 Wireless Syringe Infusion Pump, Version 1.1, 1.5, and 1.6.
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (1.85%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
An Improper Access Control issue was discovered in Smiths Medical Medfusion 4000 Wireless Syringe Infusion Pump, Version 1.1, 1.5, and 1.6. The FTP server on the pump does not require authentication if the pump is configured to allow FTP connections.
- CVSS 3.0
- 8.1 HIGHCVSS:3.0/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H
- EPSS
- 1.85% probability · 79th percentile
- Public exploits
- None in Exploit-DB
- CISA KEV
- Not listed
- Weakness
- CWE-306
- Affected
- smiths-medical/medfusion 4000 wireless syringe infusion pump
- Source
- ics-cert@hq.dhs.gov
EPSS 1.9% since 27 October 2026; no change recorded yet. Points are recorded when the score first appears and whenever it moves by a percentage point or more.
References
- http://www.securityfocus.com/bid/100665Third Party Advisory, VDB Entry
- https://ics-cert.us-cert.gov/advisories/ICSMA-17-250-02AThird Party Advisory, US Government Resource
- http://www.securityfocus.com/bid/100665Third Party Advisory, VDB Entry
- https://ics-cert.us-cert.gov/advisories/ICSMA-17-250-02AThird Party Advisory, US Government Resource
Source: NVD record, EPSS from FIRST.org, KEV from CISA, exploits from Exploit-DB. Refreshed daily. Download this record as JSON.